FATE Chart
- 52-Week Range: $21.14 - $95.73
- Market Capitalization: $2.18B
- Short Percentage: 0%
- Target Price: $86.53
- Shares Outstanding: 96.63M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
FATE released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2022 Financial ResultsGlobeNewsWire | April 22nd
- Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 28th
- Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire | February 16th
- Fate Therapeutics Showcases Interim Data From FT596 Cell Program In LymphomaBenzinga | December 14th
- Fate Therapeutics to Host Virtual Event at the 2021 ASH Annual MeetingGlobeNewsWire | December 8th
- Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 5th
- Fate Therapeutics Announces Eight Presentations at the 2021 ASH Annual MeetingGlobeNewsWire | November 4th
- Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2021 Financial ResultsGlobeNewsWire | October 25th
Company Info
Website: https://www.fatetherapeutics.com
Address: 12278 Scripps Summit Drive, San Diego, CA, United States, 92131
Sector: Healthcare
Industry: Biotechnology
Full time employees: 449
Address: 12278 Scripps Summit Drive, San Diego, CA, United States, 92131
Sector: Healthcare
Industry: Biotechnology
Full time employees: 449
$FATE only getting stronger
$FATE Buy it up so it crashes harder in the next two trading days
$FATE Moon soon
$FATE yeah we're going green today
$FATE MACD turned bullish
$FATE the price is wrong
$FATE MACD turned bullish
$FATE Pack it up boys.
$FATE Holding Strong since January ??????????
$FATE buy the dip?